The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones
Abstract
The fluoroquinolones interact with 2 bacterial targets, the related enzymes DNA gyrase and topoisomerase IV, both of which are involved in DNA replication. Quinolones form complexes of these enzymes with DNA, complexes that block movement of the DNA-replication fork and thereby inhibit DNA replication. Many older quinolones differ in their relative activities against gyrase and topoisomerase IV in a bacterial cell, having greater potency against gyrase than against topoisomerase IV in many gram-negative bacteria and greater potency against topoisomerase IV than against gyrase in many gram-positive bacteria. Several newer quinolones appear to have more closely balanced activity against these enzymes. Resistance to fluoroquinolones occurs as a result of mutational amino acid substitutions in the subunits of the more sensitive (or primary-target) enzyme within the cell. If, however, both enzymes are similarly susceptible to a fluoroquinolone, then the level of resistance caused by a primary-target mutation may be low and may be limited by the sensitivity of the secondary target. Fluoroquinolones also differ in the extent to which common bacterial multidrug efflux pumps affect their activity, with some compounds being unaffected by resistance mechanisms because of overexpression of such pumps. Newer fluoroquinolone interaction with dual targets and avoidance of efflux-resistance mechanisms may each contribute to the lower frequencies of selection of resistant mutants in the laboratory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, J. C. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.003223 · Cited by 1,832
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Mechanisms of fluoroquinolone resistance
Hooper, D. C. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0068 · Cited by 488
Self-citationYoshida, H., Bogaki, M., Nakamura, S., Ubukata, K., & Konno, M. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.12.6942-6949.1990 · Cited by 479
Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus
Kaatz, G. W., Seo, S. M., & Ruble, C. A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1086 · Cited by 413
Topoisomerase IV is a target of quinolones in Escherichia coli.
Khodursky, A. B., Zechiedrich, E. L., & Cozzarelli, N. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11801 · Cited by 378
Ferrero, L., Cameron, B., Manse, B., Lagneaux, D., Crouzet, J., Famechon, A., & Blanche, F. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00458.x · Cited by 378
Gill, M. J., Brenwald, N. P., & Wise, R. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.187 · Cited by 259
Ng, E. Y., Trucksis, M., & Hooper, D. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1881 · Cited by 232
Self-citationNg, E. Y., Trucksis, M., & Hooper, D. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1345 · Cited by 226
Self-citationDNA Gyrase and Topoisomerase IV Are Dual Targets of Clinafloxacin Action in Streptococcus pneumoniae
Pan, X.-S., & Fisher, L. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2810 · Cited by 215
Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli
Hooper, D. C., Wolfson, J. S., Souza, K. S., Tung, C., McHugh, G. L., & Swartz, M. N. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.4.639 · Cited by 211
Self-citationZechiedrich, E. L., Khodursky, A. B., & Cozzarelli, N. R. (1997) · Genes & Development · doi:10.1101/gad.11.19.2580 · Cited by 210
Bacterial Topoisomerases, Anti‐Topoisomerases, and Anti‐Topoisomerase Resistance
Hooper, D. C. (1998) · Clinical Infectious Diseases · doi:10.1086/514923 · Cited by 161
Self-citationHiasa, H., Yousef, D. O., & Marians, K. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26424 · Cited by 136
Mechanisms of Quinolone Resistance
Hooper, D. C. (2014) · ASM Press eBooks · doi:10.1128/9781555817817.ch3 · Cited by 129
Self-citationThe mode of action of 4-quinolones and possible mechanisms of resistance
Smith, J. T. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.supplement_d.21 · Cited by 125
Pan, X.-S., & Fisher, L. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1129 · Cited by 119
Piddock, L. J. V., Johnson, M. M., Ricci, V., & Hill, S. L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2956 · Cited by 95
Takenouchi, T., Tabata, F., Iwata, Y., Hanzawa, H., Sugawara, M., & Ohya, S. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1835 · Cited by 79
Bellido, J. L. M., Manzanares, M. A. A., Andrés, J., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.354 · Cited by 49
Schmitz, F., Hertel, B., Hofmann, B., Scheuring, S., Verhoef, J., Fluit, A. C., Heinz, H., Köhrer, K., & Jones, M. E. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.4.561 · Cited by 31
Cited by
Multidrug Resistance in Bacteria
Nikaido, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145923 · Cited by 1,682
Rai, M. K., Deshmukh, S. D., Ingle, A. P., & Gade, A. K. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05253.x · Cited by 1,524
Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success
Redgrave, L. S., Sutton, S. B., Webber, M. A., & Piddock, L. J. V. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.04.007 · Cited by 1,008
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone Antibacterial Agents
Mitscher, L. A. (2005) · Chemical Reviews · doi:10.1021/cr030101q · Cited by 781
Metadata
- Authors
- Hooper, D. C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-08-01
- Volume
- 31
- Issue
- Supplement_2
- Pages
- S24-S28
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2149410208
- Cited by
- 409
- References
- 22
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.